Physician profile
Nardia Sokol
NPI 1700308525
$10,711.60
in general payments reported to CMS, 2019-2025
15 companies · $2,250 in 2025
The $2,250 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $684 · 2022: $6,657 · 2023: $738 · 2024: $383 · 2025: $2,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,934 · Travel and Lodging: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,933.66 |
| Travel and Lodging | $1,437.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,396.52 | 2022 | |
| Treace Medical Concepts, INC. | $1,424.90 | 2022-2025 | |
| Smith+Nephew, INC. | $1,227.99 | 2021-2025 | Grafix Pl, Collagenase Santyl |
| Medical Device Business Services, INC. | $1,171.46 | 2021-2025 | Motoband |
| Evolution Surgical, INC | $834.50 | 2021-2025 | |
| Depuy Synthes Sales INC. | $191.91 | 2025 | Motoband |
| Osteomed LLC | $146.29 | 2021 | |
| Surgenex LLC | $99.87 | 2025 | Surgraft, Pellograft, Surmatrix |
| Polymedics Innovations INC. | $75.17 | 2023 | |
| Stryker Corporation | $34.84 | 2023 | Ortholoc 3di, Variax |
| Hartmann USA, INC. | $31.10 | 2023 | Zetuvit Plus |
| Next Science LLC | $24.69 | 2022 | |
| Ossio INC | $24.20 | 2023 | |
| Organogenesis INC. | $14.96 | 2025 | Puraply Wound Matrix |
| Mimedx Group, INC. | $13.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nardia Sokol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.